// App-Quantinova.ai

: Asparagine Bioavailability Regulates the Translation of MYC oncogene in Lymphoid Malignancies

Researchers

Presenter

  • Sankalp Srivastava

Principal Investigators

  • Jie Jiang

  • Gretchen Seim

  • Jagannath Misra

  • Utpal Dave

  • Reuben Kapur

  • Jiehao Zhou

  • Jing Fan

  • Ronald Wek

  • Ji Zhang

Medical Centers

  • Morgridge Institute for Research, University of Wisconsin-Madison, Madison, WI

  • Indiana University, Indianapolis, IN

  • Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN

  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN

  • Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, INDIANAPOLIS, IN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Hematological malignancies

  • B cell lymphomas

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Asparaginase

  • Rapacan

Outcome

  • N/A


Study Design

  • Bioavailability

  • Controlled

  • Global

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A